Stock Code: 300381 stock abbreviation: Guangdong Vtr Bio-Tech Co.Ltd(300381)
Bond Code: 123018 bond abbreviation: profit convertible bond Announcement No.: 2022-021 Guangdong Vtr Bio-Tech Co.Ltd(300381)
Report on major asset sales and related party transactions (Draft) (Revised)
Announcement of revised instructions
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Guangdong Vtr Bio-Tech Co.Ltd(300381) (hereinafter referred to as the “company”, “listed company” and ” Guangdong Vtr Bio-Tech Co.Ltd(300381) “) received the inquiry letter on the restructuring of Guangdong Vtr Bio-Tech Co.Ltd(300381) issued by Shenzhen Stock Exchange on February 16, 2022 (GEM non licensed restructuring inquiry letter [2022] No. 2) (hereinafter referred to as the “inquiry letter”). According to the requirements of the inquiry letter, the company actively organized relevant parties to respond to the questions raised in the inquiry letter, and revised, supplemented and improved the report on Guangdong Vtr Bio-Tech Co.Ltd(300381) major asset sale and related party transactions (Draft) (hereinafter referred to as the “draft”), The main amendments are as follows (unless otherwise specified, the abbreviations in the table below have the same meaning as those listed in the “interpretation” section of the draft):
1. The supplementary disclosure in “VI. (VII) information of controlling shareholders of the counterparty” of “Chapter III basic information of the counterparty” is as follows:
“5. Equity and control relationship
The equity structure of Desano is as follows:
The ultimate actual controller of desaino, the controlling shareholder of Shengchuang pharmaceutical, is Xu Shengping. Xu Shengping directly holds 7.20% of the equity of desaino, and indirectly controls 34.81%, 19.20% and 6.97% of the equity of desaino through Shanghai desaino Industrial Development Co., Ltd., Yichun Sano Jiayang enterprise management center (limited partnership) and Shanghai nuoxin Industrial Co., Ltd. Xu Shengping controls 68.18% of the equity of Desano in total through direct and indirect ways, and is the actual controller of Desano. His resume is as follows:
Xu Shengping, male, Bachelor of science and economics, has successively served as the business manager of Sinochem Tianjin Import and Export Corporation, the chairman of Shanghai desaino International Trade Co., Ltd., the chairman of Shanghai desaino Industrial Co., Ltd., the chairman of Shanghai desaino Pharmaceutical Development Co., Ltd. and the chairman of Shanghai Chuang Nuo Pharmaceutical Group Co., Ltd.
2. In “Chapter XII other important matters” of “VI. self inspection on the trading of shares of listed companies by relevant subjects involved in this transaction”, the self inspection results of the trading of shares of listed companies by relevant subjects involved in this transaction are supplemented and disclosed:
“According to the inquiry certificate on Shareholding and share change of information disclosure obligors, the detailed list of shareholder share changes issued by the registration and Clearing Company and the self-examination report issued by the institutions and personnel within the scope of self-examination, the transactions of relevant institutions and personnel during the self-examination period are as follows:
(I) Chen Shaowu
Name, identity / date of related party transaction number of transactions (shares) balance number of shares (shares) transaction type (purchase / sale)
Actual control of the company
Chen Shaowu made by Chen shaomei 2500000.00 6275000.00 sold on June 18, 2021
My brother
Chen Shaowu is the elder brother of Chen shaomei, the actual controller of Guangdong Vtr Bio-Tech Co.Ltd(300381) and the initial original shareholder of Guangdong Vtr Bio-Tech Co.Ltd(300381) .
Chen Shaowu issued a letter of commitment on the above-mentioned trading of shares of listed companies:
“1. I promise that I have never inquired through any non-public channels or used any inside information to buy or sell Guangdong Vtr Bio-Tech Co.Ltd(300381) shares and seek benefits for myself; I and my immediate family members do not disclose relevant inside information or suggest others to buy or sell Guangdong Vtr Bio-Tech Co.Ltd(300381) shares, engage in market manipulation and other prohibited transactions.
2. The stock account is opened in my own name; Buying and selling Guangdong Vtr Bio-Tech Co.Ltd(300381) shares during the self inspection period is an investment decision and investment behavior independently made by myself based on the information already disclosed in the securities market and personal judgment. There is no situation of obtaining or using insider information for trading, and there is no motivation to obtain or use insider information for stock investment.
3. I promise that if the above situation is false or major omission, I will bear all relevant legal liabilities. “
(II) he Lizhao
Name, identity / date of related party transaction number of transactions (shares) balance number of shares (shares) transaction type (purchase / sale)
2021-08-09 10000.00 49700.00 sold
2021-08-16 10000.00 39700.00 sold
He Lizhao counterparty’s sale of 39700.00 0.00 on 2021-08-18
one
2021-12-21 4100.00 purchase
2022-01-07 4100.00 sold
He Lizhao is the counterparty of this major asset sale.
He Lizhao issued a letter of commitment on the above-mentioned trading of shares of listed companies:
“1. I promise that I have never inquired through any non-public channels or used any inside information to buy or sell Guangdong Vtr Bio-Tech Co.Ltd(300381) shares and seek benefits for myself; I and my immediate family members do not disclose relevant inside information or suggest others to buy or sell Guangdong Vtr Bio-Tech Co.Ltd(300381) shares, engage in market manipulation and other prohibited transactions.
2. The stock account is opened in my own name; Buying and selling Guangdong Vtr Bio-Tech Co.Ltd(300381) shares during the self inspection period is an investment decision and investment behavior independently made by myself based on the information already disclosed in the securities market and personal judgment. There is no situation of obtaining or using insider information for trading, and there is no motivation to obtain or use insider information for stock investment.
3. I promise that if the above situation is false or major omission, I will bear all relevant legal liabilities.
”
(III) Zhou Weimeng
Name, identity / date of related party transaction number of transactions (shares) balance number of shares (shares) transaction type (purchase / sale)
2021-4-22 1000.00 2500.00 sold
Zhou Weimeng xinhexin finance 2021-6-30 500 2000.00 sales
chief inspector
2021-7-19 2000.00 0 sold
Zhou Weimeng is a senior manager of the target company.
Zhou Weimeng issued a letter of commitment on the above-mentioned trading of shares of listed companies:
“1. I promise that I have never inquired through any non-public channels or used any inside information to buy or sell Guangdong Vtr Bio-Tech Co.Ltd(300381) shares and seek benefits for myself; I and my immediate family members have not disclosed relevant inside information or suggested others to buy or sell Guangdong Vtr Bio-Tech Co.Ltd(300381) Prohibited trading activities such as stock and market manipulation. 2. The stock account is opened in my own name; Buying and selling Guangdong Vtr Bio-Tech Co.Ltd(300381) shares during the self inspection period is an investment decision and investment behavior independently made by myself based on the information already disclosed in the securities market and personal judgment. There is no situation of obtaining or using insider information for trading, and there is no motivation to obtain or use insider information for stock investment.
3. I promise that if the above situation is false or major omission, I will bear all relevant legal liabilities. “
(IV) Zhang Bo
Name, identity / date of related party transaction number of transactions (shares) balance number of shares (shares) transaction type (purchase / sale)
2021-05-18 200.00 3800.00 purchase
2021-06-03 100.00 3700.00 sold
2021-06-17 100.00 3800.00 purchase
2021-06-24 200.00 3600.00 sold
2021-06-28 200.00 3400.00 sold
Purchased by keyixin general manager on June 29, 2021 at 200.00 and 3600.00
Zhang Boli and Zhang Xiaodong
Spouse 2021-07-09 200.00 3800.00 purchase
2021-07-21 100.00 3700.00 sold
2021-07-26 200.00 3900.00 purchase
2021-07-28 100.00 4000.00 purchase
2021-08-03 200.00 3800.00 sold
2021-08-04 100.00 3700.00 sold
2021-08-05 100.00 3800.00 purchase
2021-08-06 200.00 4000.00 purchase
2021-09-01 200.00 3800.00 sold
2021-11-17 300.00 3500.00 sold
2021-12-21 300.00 3200.00 sold
2021-12-22 1700.00 1500.00 sold
2021-12-24 500.00 2000.00 purchase
2021-12-27 1500.00 500.00 sold
2021-12-28 300.00 800.00 purchase
2021-12-29 300.00 500.00 sold
2021-12-30 400.00 100.00 sold
